Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation: An economic perspective
Russell D. Hull*, Gary E. Raskob, Graham F. Pineo, William Feldstein, David Rosenbloom, Amirain Gafni, David Green, Joseph Feinglass, Arthur A. Trowbridge, C. Gregory Elltott, Robert G. Lerner, Rollin Brant
Dive into the research topics of 'Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation: An economic perspective'. Together they form a unique fingerprint.